Viewing Study NCT00085566


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-29 @ 6:28 PM
Study NCT ID: NCT00085566
Status: COMPLETED
Last Update Posted: 2016-01-20
First Post: 2004-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult glioblastoma View
None recurrent prostate cancer View
None recurrent adult brain tumor View
None stage IV prostate cancer View
None adult giant cell glioblastoma View
None adult gliosarcoma View